To evaluate the long-term effects of N-acetyl-L-leucine (NALL) in people with Niemann-Pick disease type C (NPC).
Strupp et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: